XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings (Loss) Per Share
6 Months Ended
Jul. 02, 2023
Earnings Per Share [Abstract]  
Earnings (Loss) Per Share Earnings (Loss) Per Share
The reconciliation of basic and diluted earnings (loss) per share on common stock for the second quarter and June year-to-date 2023 and 2022 follows (in millions of dollars except per share data):
 Second QuarterJune Year to Date
 2023202220232022
Net earnings (loss)$7.5 $2.2 $18.4 $(45.4)
Less: earnings allocated to participating securities(0.2)— (0.4)— 
Net earnings (loss) available to common shareholders$7.3 $2.2 $18.0 $(45.4)
Average shares outstanding (millions):
Basic36.0 37.9 36.5 38.3 
Dilutive share awards0.4 0.3 0.4 — 
Diluted36.4 38.2 36.9 38.3 
Basic earnings (loss) per share$0.20 $0.06 $0.49 $(1.19)
Diluted earnings (loss) per share$0.20 $0.06 $0.49 $(1.19)

Dilutive share awards are related to deferred common stock related to the non-employee directors deferred compensation plan and performance shares for the second quarter of 2023 and 2022 and June year-to-date 2023 (see Stock-Based Compensation footnote for a description of performance shares). Due to our net loss in June year-to-date 2022, potentially dilutive shares primarily related to deferred common stock associated with the non-employee directors deferred compensation plan of 0.2 million shares had an anti-dilutive effect on diluted earnings per share and were excluded from the computation for June year-to-date 2022. Dividends paid per share for Class A and Class B common stock were $0.075 for the second quarter of 2023 and 2022, $0.15 for June year-to-date 2023 and $0.125 for June year-to-date 2022.
In connection with our $50.0 million Class A share repurchase program authorized by the Company's board of directors in November 2022, the Company repurchased 982,565 shares for $16.5 million during the second quarter of 2023 and 2,082,293 shares for $34.8 million through June year-to-date 2023. A total of $7.4 million remains available under the share repurchase program. The repurchase program expires in November 2023.